Protease-stable DARPins as promising oral therapeutics is a research paper published in Protein Engineering Design and Selection (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01GM079190
CST* Foundation and National Institutes of Health
Grant: DP2AI136600
CST* Foundation and National Institutes of Health
Grant: R21AI126035
NIAID NIH HHS
Grant: R01 AI116895
NIAID NIH HHS
Grant: R21 AI121605
NIAID NIH HHS
Grant: U01 AI124290
NIAID NIH HHS
Grant: R21 AI126025
NIAID NIH HHS
Grant: R56 AI155917
National Institutes of Health
Grant: 5R01AI116895-04
Mechanisms of Clostridium difficile spore germination
National Institutes of Health
Grant: 1R56AI155917-01A1
Oral Protein Therapeutics Against C. difficile Associated Colitis
National Institutes of Health
Grant: 5R01AI020990-03
HUMAN SUPPRESSOR CELL AMPLIFICATION SYSTEMS
National Institutes of Health
Grant: 5U01AI124290-04
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
National Institutes of Health
Grant: 1R01GM079190-01A2
Understanding protein radicals
FWCI
0.19
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals